norethisterone acetate controlled release tablets this tablet is use for??
Reading File
Finding Sources
Searching the Web
norethisterone acetate controlled release tablets uses indications
Here is a complete overview of Norethisterone Acetate (NETA) Controlled Release Tablets and their uses:
What is Norethisterone Acetate (NETA)?
NETA is a synthetic progestin (progesterone receptor agonist) - a prodrug that converts to norethisterone in the body. The controlled release (CR) formulation is designed to maintain steady drug levels in the blood, reduce dosing frequency, improve patient compliance, and minimize gastrointestinal side effects and dose-related adverse events.
Uses / Indications
1. Abnormal Uterine Bleeding (AUB) - PRIMARY USE in India
The CR tablet was specifically developed for AUB management. Controlled-release NETA maintains constant blood levels, making it highly effective for:
- Heavy menstrual bleeding (HMB)
- Dysfunctional uterine bleeding (DUB)
- Hormonal imbalance-related bleeding
Dose for CR formulation: typically 10-15 mg/day depending on indication.
2. Secondary Amenorrhea
Used to restore menstruation when periods have stopped due to hormonal imbalance (not due to pregnancy or structural causes).
3. Endometriosis
NETA is used to suppress endometrial tissue growth and reduce associated pelvic pain. It is also used as add-back therapy alongside GnRH agonists (at doses like 5 mg/day) to reduce bone loss during GnRH treatment.
4. Oral Contraception
In combination with estrogen (e.g., ethinylestradiol), NETA is a component of combined oral contraceptive pills (OCPs). It prevents ovulation and thickens cervical mucus.
5. Menopausal Hormone Therapy (HRT)
Combined with estradiol (as tablets or transdermal patches), NETA protects the endometrium in postmenopausal women on estrogen therapy.
6. Delay of Menstruation
NETA is more effective than combined OC pills in delaying menstruation (e.g., for travel, surgery, or special events).
7. Endometrial Hyperplasia / Cancer Protection
Provides endometrial protection in women on unopposed estrogen therapy.
How It Works
- Acts as a progesterone receptor agonist - mimics natural progesterone
- Causes endometrial atrophy (thins the uterine lining), stopping abnormal bleeding
- Suppresses FSH and LH from the pituitary, preventing ovulation
- Thickens cervical mucus, blocking sperm penetration
Why Controlled Release?
Compared to immediate-release tablets, the CR formulation:
- Maintains constant drug plasma levels (avoids peaks and troughs)
- Reduces gastrointestinal irritation
- Allows once-daily dosing instead of multiple doses
- Reduces dose-related side effects (nausea, breakthrough bleeding)
- Improves patient compliance
A 2024 Indian clinical trial (CEASE-1, Torrent Pharmaceuticals) specifically assessed the safety and utilization of NETA-CR tablets for AUB management in real-world settings in India.
Key Side Effects to Monitor
- Menstrual irregularities / spotting
- Headache, nausea, breast tenderness
- Mood changes
- Acne, increased hair growth (mild androgenic effect)
- Rare: thromboembolism (DVT, PE)
Contraindications
- Known or suspected pregnancy
- Undiagnosed vaginal bleeding
- History of breast cancer
- Active deep vein thrombosis or thromboembolic disorders
- Severe liver disease
In summary, NETA CR tablets are primarily prescribed for abnormal uterine bleeding in Indian clinical practice, and also for endometriosis, HRT, contraception, amenorrhea, and menstrual delay. The controlled release formulation is an Indian pharmaceutical advancement (notably by Torrent Pharmaceuticals) aimed at better tolerability and compliance over standard formulations.
Texakind??
Searching the Web
Texakind tablet uses composition ingredients
Searching the Web
Texakind medicine brand India
Here is a complete breakdown of Texakind - a brand by Mankind Pharmaceuticals Ltd.
Texakind - Brand Overview
Texakind comes in two variants:
| Variant | Composition | Category |
|---|---|---|
| Texakind (plain) | Tranexamic Acid 500 mg | Antifibrinolytic / Haemostatic |
| Texakind-MF | Tranexamic Acid 500 mg + Mefenamic Acid 250 mg | Haemostatic + Anti-inflammatory |
Texakind (Tranexamic Acid 500 mg)
Mechanism of Action
Tranexamic acid is an antifibrinolytic agent. It blocks the breakdown of fibrin clots by inhibiting plasminogen activation, thereby promoting clot stability and reducing blood loss.
Uses
- Heavy menstrual bleeding (Menorrhagia) - primary use
- Post-surgical bleeding control
- Dental procedure bleeding (especially in patients on anticoagulants)
- Nosebleeds (Epistaxis)
- Bleeding disorders (e.g., haemophilia)
- Trauma-related excessive bleeding
Texakind-MF (Tranexamic Acid 500 mg + Mefenamic Acid 250 mg)
Mechanism of Action
- Tranexamic Acid - stops clot breakdown, reduces blood loss
- Mefenamic Acid - NSAID (prostaglandin inhibitor), reduces menstrual pain and cramps
Uses
- Menstrual pain (dysmenorrhoea) + heavy bleeding together
- Painful, heavy periods - treats BOTH symptoms simultaneously
- Lower abdominal cramps before and during menses
Side Effects
| Common | Serious (Rare) |
|---|---|
| Nausea, vomiting | Thromboembolism (DVT, PE) |
| Diarrhoea | Fits / Seizures |
| Headache | Vision changes / colour vision loss |
| Backache | Allergic reactions |
Contraindications
- History of blood clotting disorders (DVT, PE)
- Subarachnoid haemorrhage
- After coronary artery bypass surgery (CABG)
- Pregnancy (especially last trimester) - for the MF variant
- Acquired defective colour vision
- Severe kidney disease
Key Points
- Prescription required
- Manufactured by Mankind Pharmaceuticals Ltd., Haridwar, India
- Take with or without food, spaced evenly throughout the day
- Does NOT act as a contraceptive
- Regular eye check-ups recommended for long-term use
This is a shared conversation. Sign in to Orris to start your own chat.